{
    "title": "Breast Cancer medicine pain reduced with 4300 IU vitamin D \u2013 RCT",
    "slug": "breast-cancer-medicine-pain-reduced-with-4300-iu-vitamin-d-rct",
    "aliases": [
        "/Breast+Cancer+medicine+pain+reduced+with+4300+IU+vitamin+D+\u2013+RCT+June+2012",
        "/2962"
    ],
    "tiki_page_id": 2962,
    "date": "2012-06-26",
    "categories": [
        "Pain - chronic",
        "Cancer - after diagnosis",
        "Intervention"
    ],
    "tags": [
        "Cancer - after diagnosis",
        "Intervention",
        "Pain - chronic",
        "breast cancer",
        "cancer",
        "dosage",
        "vitamin d"
    ]
}


### Highlight from [Vitamin D May Help Breast Cancer Survivors Stay on Track ](http://www.medscape.com/viewarticle/766273%20)Medscape Medical News

2012 Annual Meeting of the American Society of Clinical OncologyÂ®

* aromatase inhibitors

> half of the women have severe musculoskeletal pain from these agents, and 18% to 30% report fatigue, <span>[resulting in]</span> a discontinuation rate of about 10% each year,"

* 30,000 IU of oral vitamin D3 weekly on starting letrozole therapy achieved significant benefits in terms of fatigue, joint pain, and disability from joint pain.

* Using the Simple Descriptive Pain Intensity 

> 37% of women receiving vitamin D3 

> 51% of those in the placebo group

* adverse quality of life events = 42% vs 72%